Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Proton vs photon radiation therapy for glioblastoma: Maximizing information from trial

    Research output: Contribution to journalLetterResearchpeer-review

  4. Diagnostic Accuracy and Clinical Impact of [ 18F]FET PET in Childhood CNS tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Letter to the Editor. Copenhagen grading of meningioma

    Research output: Contribution to journalLetterResearchpeer-review

  3. Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Expression, prognostic significance and therapeutic implications of PD-L1 in gliomas

    Research output: Contribution to journalReviewResearchpeer-review

  • Arnon Møldrup Knudsen
  • Bo Halle
  • Oriane Cédile
  • Mark Burton
  • Christina Baun
  • Helge Thisgaard
  • Atul Anand
  • Christopher Hubert
  • Mads Thomassen
  • Signe Regner Michaelsen
  • Birgitte Brinkmann Olsen
  • Rikke Hedegaard Dahlrot
  • Rolf Bjerkvig
  • Justin Durla Lathia
  • Bjarne Winther Kristensen
View graph of relations

BACKGROUND: Glioblastomas are highly resistant to therapy, and virtually all patients experience tumor recurrence after standard-of-care treatment. Surgical tumor resection is a cornerstone in glioblastoma therapy, but its impact on cellular phenotypes in the local postsurgical microenvironment has yet to be fully elucidated.

METHODS: We developed a preclinical orthotopic xenograft tumor resection model in rats with integrated 18F-FET PET/CT imaging. Primary and recurrent tumors were subject to bulk and single-cell RNA sequencing. Differentially expressed genes and pathways were investigated and validated using tissue specimens from the xenograft model, 23 patients with matched primary/recurrent tumors, and a cohort including 190 glioblastoma patients. Functional investigations were performed in vitro with multiple patient-derived cell cultures.

RESULTS: Tumor resection induced microglia/macrophage infiltration, angiogenesis as well as proliferation and upregulation of several stem cell-related genes in recurrent tumor cells. Expression changes of selected genes SOX2, POU3F2, OLIG2, and NOTCH1 were validated at the protein level in xenografts and early recurrent patient tumors. Single-cell transcriptomics revealed the presence of distinct phenotypic cell clusters in recurrent tumors which deviated from clusters found in primary tumors. Recurrent tumors expressed elevated levels of pleiotrophin (PTN), secreted by both tumor cells and tumor-associated microglia/macrophages. Mechanistically, PTN could induce tumor cell proliferation, self-renewal, and the stem cell program. In glioblastoma patients, high PTN expression was associated with poor overall survival and identified as an independent prognostic factor.

CONCLUSION: Surgical tumor resection is an iatrogenic driver of PTN-mediated self-renewal in glioblastoma tumor cells that promotes therapeutic resistance and tumor recurrence.

Original languageEnglish
Issue number7
Pages (from-to)1074-1087
Number of pages14
Publication statusPublished - 1 Jul 2022

Bibliographical note

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail:

    Research areas

  • Animals, Brain Neoplasms/drug therapy, Carrier Proteins, Cytokines, Glioblastoma/genetics, Humans, Neoplasm Recurrence, Local/pathology, Neoplastic Stem Cells/metabolism, Positron Emission Tomography Computed Tomography, Rats, Stem Cells, Tumor Microenvironment, self-renewal, recurrence, pleiotrophin, glioblastoma, tumor resection

ID: 71673272